Pen Needles Market Growth Driven by Rising Diabetes Prevalence and Increasing Adoption of Insulin and GLP-1 Therapies

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pen Needles Market- (By Type (Standard Pen Needles, Safety Pen Needles), By Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm), By Mode of Purchase (Retail, Non-retail), By Therapy (Insulin, Glucagon-Like Peptide-1, Growth Hormone, Other therapies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Pen Needles Market is valued at USD 1.66 Bn in 2024, and it is expected to reach USD 3.43 Bn by the year 2031, with a CAGR of 10.95% during a forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2733

Pen needles are precision-engineered medical devices designed for use with pen injectors, primarily facilitating the subcutaneous administration of insulin for individuals managing diabetes with multiple daily injections. The global pen needle market is experiencing substantial growth, driven by several key factors, including the rising prevalence of diabetes worldwide, increasing preference for self-administered injectable therapies, and the availability of a diverse range of pen needle options tailored to meet varying patient requirements. Additionally, the growing focus on home-based healthcare and patient self-management is contributing to the market's expansion.

The transition from conventional syringes to pen injectors-due to their user-friendly design, improved patient adherence, and enhanced safety features-has accelerated market adoption. Innovations in pen needle design, particularly those aimed at minimizing injection discomfort and enhancing safety, are further supporting market development. Leading manufacturers are actively investing in product innovation, exemplified by next-generation solutions such as the BD NanoTM 2nd Generation Pen Needles, which are specifically engineered to optimize precision and comfort during administration.

Moreover, the broad availability of pen needles through multiple distribution channels, including retail pharmacies, e-commerce platforms, and healthcare facilities, is strengthening market penetration and supporting sustained growth across key global regions.

List of Prominent Players in the Pen Needles Market:
• Becton, Dickinson, and Company (US),
• Novo Nordisk A/S (Denmark),
• Ypsomed Holding AG (Switzerland),
• B. Braun Melsungen AG (Germany),
• Owen Mumford (UK),
• Terumo Corporation (Japan),
• Nipro Corporation (Japan)
• Allison Medical (US),
• AdvaCare Pharma (US),
• Berpu Medical Technology (China),
• ARKRAY (Japan),
• GlucoRx (UK),
• HTL-STREFA (Poland),
• UltiMed, (US),
• Hindustan Syringes and Medical Devices (India),
• Artsana Group (Italy),
• PromiseMed Diabetes Care (Canada),
• Montmed (Canada),
• Trividia Health (US),
• VOGT Medical Vertrieb (Germany),
• Van Heek Medical (Netherlands),
• Simple Diagnostics (US),
• Lyon (Turkey),
• Links Medical Products (US),
• MHC Medical Products (US)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The increasing prevalence of chronic conditions-such as diabetes, cardiovascular diseases, and multiple sclerosis-has driven substantial demand for reliable and frequent drug delivery solutions. Pen injectors have become a preferred method for administering injectable therapies due to their ease of use, consistent performance, and capability to support self-administration without direct healthcare professional supervision.

Pen needles, as the detachable components of these devices, are critical for ensuring accurate and effective delivery, with factors such as needle length and sharpness influencing successful administration to target tissue. As chronic disease incidence continues to rise globally, demand for advanced pen needle technologies that enhance patient adherence and facilitate efficient management of large patient populations is expected to grow.

Challenges:
Despite their advantages, pen needles carry certain risks, including potential needlestick injuries, infections, patient discomfort, and dosing errors, which may result in complications such as hyperglycemia. For instance, some insulin pen users experience difficulties with precise dose control, prompting consideration of alternative diabetes management strategies.

In regions such as Europe, insulin pumps-featuring automated insulin suspension and lower hypoglycemia risk-are increasingly preferred over traditional pen-based therapies, presenting competitive pressure to the pen needle market. Moreover, while needle-free drug delivery systems offer potential solutions to some of the limitations associated with conventional needles, their current practical applications remain limited.

Regional Trends:
The Asia-Pacific (APAC) region is projected to exhibit strong growth in the pen needle market during the forecast period. This expansion is driven by increasing preference for pen-based delivery over traditional syringes and vials, as well as a rapidly aging population. China, in particular, is emerging as a key growth contributor, supported by the rising prevalence of diabetes.

According to the "Guidelines for the Prevention and Treatment of Diabetes in China (2020 Edition)," approximately 11.2% of Chinese adults-around 141 million individuals-are affected by diabetes, with more than half remaining undiagnosed. These statistics underscore the urgent need for accessible and effective drug delivery solutions, which is expected to sustain market growth in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2733

Recent Developments:
• In February 2023, Montmed, Inc. announced, the United States Patent and Trademark Office has issued a second US Patent 11,517,659, expanding the company's novel technology patent family that aims to help insulin users develop and implement healthy injection site rotation practices easily and seamlessly.
• In May 2022, Owen Mumford Ltd. revealed its next-generation safety pen needle will join Unifine SafeControl to enhance its diabetic care products. The first safety pen needle, Unifine SafeControl, protects healthcare professionals from needlestick accidents and ensures the full medication dose is given.
• In Jan 2019, Becton Dickinson (BD) introduced the Ergonomic Pen Needle Technology with the aim of enhancing the efficiency of injection techniques. The BD Nano(TM) second generation pen needle has obtained 510(k) clearance from the U.S. Food and Drug Administration.

Segmentation of Pen Needles Market-
By Type-
• Standard Pen Needles
• Safety Pen Needles
By Length-
• 4 mm Pen Needle
• 5 mm Pen Needle
• 6 mm Pen Needle
• 8 mm Pen Needle
• 10 mm Pen Needle
• 12 mm Pen Needle
By Mode of Purchase-
• Retail
• Non-retail
By Therapy-
• Insulin
• Glucagon-Like Peptide-1
• Growth Hormone
• Other therapies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/pen-needles-market/2733

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.